Do&#231;.Dr. Suna YAPALI

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.30, sa.7, ss.582-583, 2019 (SCI-Expanded)

Dealing with the gray zones in the management of gastric cancer: The consensus statement of the Istanbul Group

AYTAÇ E., Aslan F., ÇİÇEK B., Erdamar S., Gurses B., GÜVEN K., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , sa.7, ss.584-598, 2019 (SCI-Expanded)

COVERING THE COVER.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.29, ss.375-376, 2018 (SCI-Expanded)

Seroprevalance of hepatitis B and C infections in Turkey.

Yapali S., Hamzaoglu H. O.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.28, sa.2, ss.147-148, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

Admissions for hepatitis B reactivation in patients receiving immunosuppressive therapy remain unchanged from 1999 to 2014.

Patel A., Yapali S., Lok A.

Hepatology international , cilt.10, ss.139-46, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

Changes in characteristics of hepatitis C patients seen in a liver centre in the United States during the last decade.

Talaat N., Yapali S., Fontana R., Conjeevaram H., Lok A.

Journal of viral hepatitis , cilt.22, ss.481-8, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

Outcomes of patients with chronic hepatitis B who do not meet criteria for antiviral treatment at presentation.

Yapali S., Talaat N., Fontana R., Oberhelman K., Lok A.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association , cilt.13, 2015 (SCI-Expanded)

Does suppression of HBV replication by antiviral therapy confer the same benefit as host immune control of HBV?

Yapali S., Lok A.

Gut , cilt.63, ss.1833-4, 2014 (SCI-Expanded)

Sexual activity does not predispose to reflux episodes in patients with gastroesophageal reflux disease

BOR S., Valytova E., YAPALI S., Yildirim E., VARDAR R.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL , cilt.2, sa.6, ss.482-489, 2014 (SCI-Expanded)

Systematic review: identifying patients with chronic hepatitis C in need of early treatment and intensive monitoring--predictors and predictive models of disease progression.

Konerman M., Yapali S., Lok A.

Alimentary pharmacology & therapeutics , cilt.40, ss.863-79, 2014 (SCI-Expanded)

Management of hepatitis B: our practice and how it relates to the guidelines.

Yapali S., Talaat N., Lok A.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association , cilt.12, ss.16-26, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

Potential benefit of telbivudine on renal function does not outweigh its high rate of antiviral drug resistance and other adverse effects.

Yapali S., Lok A.

Gastroenterology , cilt.146, ss.15-9, 2014 (SCI-Expanded)

Should treatment of hepatitis B patients be based solely on liver fibrosis?

Yapali S., Lok A.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association , cilt.11, ss.1500-2, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

Giant esophageal lipoma presenting with gastroesophageal reflux symptoms.

Yapali S., Oruc N., Harman M., Aydin A.

Journal of gastrointestinal and liver diseases : JGLD , cilt.22, ss.8, 2013 (SCI-Expanded)

The role of Bernstein test with pH-impedance monitoring in different subtypes of GERD: Re-evaluation of an old technique

YAPALI S., Vardar R., Yildirim E., BOR S.

JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.47, sa.1, ss.96-97, 2013 (SCI-Expanded)

Acute presentation of autoimmune hepatitis in a patient with myasthenia gravis, thymoma, Hashimoto thyroiditis and connective tissue disorder

Yapali S., ORUÇ N., Ilgun S., YILMAZ F., AKSU K., Yilmaz M., et al.

Hepatology Research , cilt.42, sa.8, ss.835-839, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

Serum Levels of Adipokines in Patients with Chronic HCV Infection: Relationship with Steatosis and Fibrosis

TIFTIKCI A., ATUĞ Ö., YILMAZ Y., EREN F., Ozdemir F. T., Yapali S., et al.

ARCHIVES OF MEDICAL RESEARCH , cilt.40, sa.4, ss.294-298, 2009 (SCI-Expanded)

Is there a role for adipocytokines on the effect of anti-TNF treatment in an experimental model of colitis?

Yapali S., Deniz M., Eren F., Imeryuz N., Celikel C., Ozkan N., et al.

GASTROENTEROLOGY , cilt.134, sa.4, 2008 (SCI-Expanded)

Anti-TNF treatment in inflammatory bowel disease

Annals of Gastroenterology , cilt.20, sa.1, ss.48-53, 2007 (SCI-Expanded)

Diğer Dergilerde Yayınlanan Makaleler

Long-term Kinetics of Alpha-fetoprotein in Chronic Hepatitis C Patients Treated with Direct-acting Antivirals and Possible Predictive Role of AFP Response to Treatment on Development of Hepatocellular Carcinoma

Ulasoglu C., Senates B. E., YAPALI S., Dumanoglu B., Enc F., ÇOLAK Y., et al.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , cilt.27, sa.2, ss.49-52, 2021 (Hakemli Dergi) Sürdürülebilir Kalkınma

Gebeliğin Akut Yağlı Karaciğeri

Türkiye Klinikleri Gastroenterohepatoloji Dergisi , cilt.14, sa.2, ss.42-48, 2021 (Hakemli Dergi)

Sistemik Hastalıklar ve Karaciğerin Nodüler Rejeneratif Hiperplazisi

Türkiye Klinikleri Gastroenterohepatoloji Dergisi , cilt.14, sa.2, ss.104-110, 2021 (Hakemli Dergi)

Regular coffee intake improves liver enzyme levels and liver histology in patients with chronic alcohol consumption, non-alcoholic fatty liver and non-alcoholic steatohepatitis: Report of 259 cases

DEĞERTEKİN M. B., TÖZÜN A. N., Söylemez A. G., Gurtay E., Bozkurt U., YILMAZ Y., et al.

Hepatology Forum , cilt.1, sa.3, ss.88-96, 2020 (Hakemli Dergi)

Determination of the upper limits of normal serum alanine aminotransferase (ALT) level in healthy Turkish population.

Degertekin B., Tozun N., Demir F., Soylemez G., Yapali S., Bozkurt U., et al.

Hepatology forum , cilt.1, sa.2, ss.44-47, 2020 (Hakemli Dergi)

Determination of the upper limits of normal serum alanine aminotransferase (ALT) level in healthy Turkish population

Değertekin M. B., Tözün A. N., Demir F., Soylemez G., Yapalı S., Bozkurt U., et al.

Hepatology Forum , cilt.1, sa.2, ss.44-47, 2020 (Hakemli Dergi)

What hepatologists need to know about COVID-19?

Hepatology Forum , cilt.1, sa.2, ss.41-43, 2020 (Hakemli Dergi)

Nonalkolik Yağlı Karaciğer Hastalığında Noninvaziv Yöntemler

Türkiye Klinikleri , cilt.1, ss.35-40, 2019 (Hakemli Dergi)

The Role of New Viral Biomarkers in Chronic Hepatitis B: Ready to Use in the Clinical Practice?

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , cilt.24, sa.2, ss.57-60, 2018 (Hakemli Dergi) Sürdürülebilir Kalkınma

Epidemiology and viral risk factors for hepatocellular carcinoma in the Eastern Mediterranean countries

Yapalı S., Tözün A. N.

Hepatoma Resarch , cilt.4, sa.24, ss.1-10, 2018 (Hakemli Dergi)

New treatments for chronic hepatitis C infection

Yapali S., Tozun N.

MARMARA MEDICAL JOURNAL , cilt.29, ss.43-49, 2016 (Hakemli Dergi)

7 günlük standard üçlü tedaviye C ve E vitamini eklenmesiHelikobakter pilori eradikasyon oranını arttırır

GÜZELBULUT F., SEZiKLi M., ÇETiNKAYA Z. A., YAPALI S., İNCE A. T., ÖVÜNÇ O.

Akademik Gastroenteroloji , cilt.9, sa.2, ss.60-63, 2015 (Hakemli Dergi)

Should this patient be treated Best practices in identifying cirrhosis and HCC in patients infected with HBV Role of prediction models

YAPALI S., LOK A. S.

Johns Hopkins Medicine eViralHepatitis Review , cilt.3, sa.3, ss.1-12, 2013 (Hakemli Dergi)

Literatürden Seçmeler Helicobakter pilori enfeksiyonu ve özofagus hastalıkları

Skop Gastrointestinal Endoskopi Dergisi , sa.5, ss.45-47, 2011 (Hakemsiz Dergi)

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Real life efficacy and tolerability of tenofovir alafenamde fumarate in liver transplant recipients: a multicenter study

YAPALI S., GÖKCAN H., HARPUTLUOĞLU M. M. M., Ellik Z. M., Gokcen P., ADANIR H., et al.

Joint Annual International Congress of ILTS, ELITA and LICAGE, İstanbul, Türkiye, 4 - 07 Mayıs 2022, ss.107-108

EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN HEPATITIS B VIRUS-INFECTED PATIENTS WITH CHRONIC HEMODIALYSIS AND RENAL TRANSPLANTATION: A PRELIMINARY RESULT

AASLD THE LIVER MEETİNG DIGITAL EXPERIENCE, 12 - 15 Kasım 2021, cilt.74, ss.480-481

REAL LIFE EFFICACY AND TOLERABILITY OF TENOFOVIR ALAFENAMIDE FUMARATE IN PATIENTS WITH HEPATITIS B VIRUS-RELATED CIRRHOSIS AND LIVER TRANSPLANT RECIPIENTS. A-PRELIMINARY RESULT

The Liver Meeting Digital Experience-AASLD, Washington, Amerika Birleşik Devletleri, 12 - 15 Kasım 2021, cilt.74, ss.490-491

EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE IN CHRONIC HEPATITIS B PATIENTS WITH CHRONIC HEMODIALYSIS AND KIDNEY TRANSPLANTATION‐ REALITY STUDY

AASLD-TASL Hepatology Connect, 15 - 16 Ocak 2021, ss.1-2 Sürdürülebilir Kalkınma

EFFECT OF TENOFOVIR ALAFENAMIDE FUMARATE (TAF) PROPHYLAXIS FOR HEPATITIS B VIRUS REACTIVATION IN HBV-INFECTED INDIVIDUALS, WHO RECEIVED CHEMO/IMMUNOSUPPRESSIVE THERAPY

AASLD_TASL Digital Hepatology Connect, 15 - 16 Ocak 2021, ss.3-4 Sürdürülebilir Kalkınma

REAL-LIFE EFFICACY and TOLERABILITY OF TENOFOVIR ALAFENAMIDE IN SPECIAL GROUPS OF HEPATITIS B PATIENTS: LIVER TRANSPLANT RECIPIENTS AND CIRRHOSIS

AASLD_TASL Digital Hepatology Connect, 15 Ocak 2021, ss.2-3 Sürdürülebilir Kalkınma

"Hipereozinofilik sendrom benzeri klinik ile prezente olan ilaca bağlı akut karaciğer hasarı”

Yapalı S., Yucel S., Sariguzel N., Küçükmetin N., Saruc M., Ünal H. U., et al.

12. Ulusal Hepatoloji Kongresi, Antalya, Türkiye, 1 - 05 Mayıs 2019, ss.16 Sürdürülebilir Kalkınma

Esophageal high resolution manometry (ESO HRM) results in gastroesophageal reflux (GER) patientsPP352

Tiftikci A., ERSOY Ö., VARDARELİ N. E., Yapali S., kızıltaş ş., Onder O., et al.

World Congress of gastroenterology, İstanbul, Türkiye, 21 - 24 Eylül 2019

Sepsis hastalarında gelişen karaciğer işlev bozukluğu ve mortaliteyi etkileyen faktörler

rustamova n., Onder O., BAHŞİ Ş., ÇAKAR N., Yapali S., Turkel K. N., et al.

12.Ulusal hepatoloji Kongresi, Antalya, Türkiye, 1 - 05 Mayıs 2019

Case Report: Drug-induced liver injury mimicking hypereosinophilic syndrome

Yapalı S., Yucel S., Sariguzel N., Saruc M., Unal H. U., Tıftıkcı A., et al.

AASLD-TASL Connect Meeting , İstanbul, Türkiye, 15 - 16 Mart 2019, ss.34 Sürdürülebilir Kalkınma

IS TELBIVUDINE-INDUCED POLYNEUROPATHY/MYOPATHY REVERSIBLE IN LIVER TRANSPLANT RECIPIENTS?

TURAN İ., YAPALI S., BADEMKIRAN F., GÜNŞAR F., ZEYTUNLU M., ERSÖZ G., et al.

34. Ulusal Gastroenteroloji Haftası, Antalya, Türkiye, 1 - 06 Aralık 2017

Is Telbivudine-Induced Polyneuropathy/Myopathy Reversible in Liver Transplant Recipients?

TURAN İ., YAPALI S., GÜNŞAR F., ZEYTÜNLÜ M., ERSÖZ G., AKARCA U. S., et al.

68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Washington, Kiribati, 20 - 24 Ekim 2017, cilt.66

Is Telbivudine-Induced Polyneuropathy/Myopathy Reversible in Liver Transplant Recipients?

TURAN İ., YAPALI S., GÜNŞAR F., ZEYTUNLU M., ERSÖZ G., AKARCA U. S., et al.

The Liver Meeting AASLD 2017, Washington DC, USA, 20 - 24 Ekim 2017, cilt.66

Adenoma Detection Rate Varies Greatly Among Different Centers of the Same Health Group (Analyzes of 28.000 Colonoscopies Performed in 14 Centers)

Vardareli E. K., Kucukmetin N. T., Ersoy Ö., Yapali S., Degertekin B., Tiftikci A., et al.

Digestive Disease Week, Illinois, Amerika Birleşik Devletleri, 6 - 09 Mayıs 2017, cilt.85

Postgraduate Course Case Presentations Noncardiac Chest Pain

YAPALI S., BOR S., FOX M.

UEG Week 2015, Barcelona, İspanya, 24 - 28 Ekim 2015

KRONIK HEPATIT B Tedavide Yeni Neler Var

10. Ulusal Hepatoloji Kongresi, İstanbul, Türkiye, 27 - 30 Mayıs 2015 Sürdürülebilir Kalkınma

Üst GİS endoskopisi kime ne zaman

Namık Kemal Menteş Ege Gastroenteroloji Günleri, İzmir, Türkiye, 27 - 28 Şubat 2015

BARSAK VE KARACİĞER İLİŞKİSİ AŞK MI NEFRET Mİ Araya Beyni de Koyalım Gut Liver Brain Axis